GenSight Biologics
Series BGenSight Biologics raised €32M in a Series B round in Jul 2015. The company is based in Paris, France. Investors in the round: Abingworth LLP, Fidelity, HealthCap and 2 others. Data as of Nov 2026.
Amount raised
€32M
€32,174,457
Native amount
36,000,000 USD
Stage
Series B
series b
Investors
5
Provenance & confidence
UnverifiedAmount
36,000,000 USD
ECB-at-date → €32M · rate 1.1189 on 2015-06-30
High confidence
Source
No source on record — unverified.
Unverified
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
5 namedDate
Jul 2015
Round type
series b
Amount (EUR)
€32M